Who owns ANTX?
Institutional ownership of AN2 Therapeutics Inc. from Form 13F, Q2 2026
66 institutional managers reported holding AN2 Therapeutics Inc. (ANTX) in Form 13F filings for Q2 2026, with 24,584,035 shares worth $119M. The largest reported holder was Vivo Capital, LLC. Managers that filed both quarters added a net 2,689,555 shares (+12.3%). 28 opened new positions and 14 sold out.
- Funds holding
- 66
- Value held
- $119M
- New / sold out
- 28 / 14
- Net shares, same filers
- +12.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ANTX
Share of 13F holdings is each fund's shares as a share of the 24,584,035 ANTX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$6.5M
- Citadel Advisors LLC Added+$3.9M
- Commodore Capital LP Added+$2.9M
- SummitTX Capital, L.P. New+$2.9M
- Balyasny Asset Management L.P. New+$2.7M
- Geode Capital Management, LLC Added+$2.0M
- Vanguard Capital Management LLC Added+$1.1M
- State Street Corp Added+$951K
- Vanguard Portfolio Management LLC New+$869K
- Northern Trust Corp Added+$831K
Biggest sellers in Q2 2026
- Woodline Partners LP Trimmed-$2.6M
- Bank of Nova Scotia Sold out-$1.6M
- Bank of America Corp Trimmed-$1.2M
- Jane Street Group, LLC Sold out-$1.0M
- Morgan Stanley Trimmed-$894K
- Bank of Montreal Sold out-$890K
- Stonepine Capital Management, LLC Trimmed-$785K
- Ameriprise Financial Inc Trimmed-$770K
- Cantor Fitzgerald, L. P. Sold out-$684K
- Landscape Capital Management, L.l.c. Trimmed-$633K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $28.8M and sold $13.6M; 15 added and 14 trimmed.
Schedule 13D and 13G filings on ANTX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-03-16Commodore Capital LP SCHEDULE 13G filed by AN2 Therapeutics Inc.Schedule 13G
- 2026-03-13INTEGRATED CORE STRATEGIES (US) LLC SCHEDULE 13G filed by AN2 Therapeutics Inc.Schedule 13G
- 2026-02-17Almitas Capital LLC SCHEDULE 13G filed by AN2 Therapeutics Inc.Schedule 13G
- 2025-11-15Almitas Capital LLC SCHEDULE 13G filed by AN2 Therapeutics Inc.Schedule 13G
- 2025-05-07BML Investment Partners, L.P. SCHEDULE 13D filed by AN2 Therapeutics Inc.Schedule 13D
Questions about ANTX ownership
- Who owns ANTX stock?
- 66 institutional investment managers reported ANTX positions in their Form 13F filings for Q2 2026, holding 24,584,035 shares worth $119M in total. Vivo Capital, LLC reported the largest position.
- Are funds buying or selling ANTX?
- In Q2 2026, 28 managers opened new ANTX positions, 15 added, 14 trimmed and 14 sold out. Managers that filed in both quarters added a net 2,689,555 shares.
- How current is this ANTX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ANTX by CUSIP. Options are left out. ANTX news and filings · ANTX insider trades · Top funds